|
Treatment Options
|
Monoclonal Antibodies
Usually, babies receive natural substances to help fight RSV and other viruses, called antibodies, from their mothers. If a baby is born prematurely, the baby does not get enough of these virus-fighting antibodies before birth. Synagis provides the natural antibodies that specifically target RSV. Synagis is recommended for prevention of serious RSV infections in infants with bronchopulmonary dysplasia (BPD) and infants with a history of prematurity (birth before 35 weeks gestation). Drugs in the class
Palivizumab Solution for Injection
(
Palivizumab (Murine) Solution for Injection,
Synagis Solution for Injection
)
|
Note: The above information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist, or other healthcare professional. It is not intended to diagnose a health condition, but it can be used as a guide to help you decide if you should seek professional treatment or to help you learn more about your condition once it has been diagnosed.
|
